136 related articles for article (PubMed ID: 16041382)
1. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity.
Brockstedt DG; Bahjat KS; Giedlin MA; Liu W; Leong M; Luckett W; Gao Y; Schnupf P; Kapadia D; Castro G; Lim JY; Sampson-Johannes A; Herskovits AA; Stassinopoulos A; Bouwer HG; Hearst JE; Portnoy DA; Cook DN; Dubensky TW
Nat Med; 2005 Aug; 11(8):853-60. PubMed ID: 16041382
[TBL] [Abstract][Full Text] [Related]
2. Vaccine wakes from the dead.
Frankel FR
Nat Med; 2005 Aug; 11(8):833-4. PubMed ID: 16079877
[No Abstract] [Full Text] [Related]
3. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
[TBL] [Abstract][Full Text] [Related]
4. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. A single immunization near birth elicits immediate and lifelong protective immunity.
Reikie BA; Smolen KK; Fortuno ES; Loeffler DI; Cai B; Blimkie D; Kollmann TR
Vaccine; 2010 Dec; 29(1):83-90. PubMed ID: 21034825
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with irradiated Listeria induces protective T cell immunity.
Datta SK; Okamoto S; Hayashi T; Shin SS; Mihajlov I; Fermin A; Guiney DG; Fierer J; Raz E
Immunity; 2006 Jul; 25(1):143-52. PubMed ID: 16860763
[TBL] [Abstract][Full Text] [Related]
8. Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains.
Lauer P; Hanson B; Lemmens EE; Liu W; Luckett WS; Leong ML; Allen HE; Skoble J; Bahjat KS; Freitag NE; Brockstedt DG; Dubensky TW
Infect Immun; 2008 Aug; 76(8):3742-53. PubMed ID: 18541651
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW; Jacobs AR; Tang J; Desai P; Kopp EB; Huang Y; Song L; Nakaar V; Powell TJ
Vaccine; 2007 Jan; 25(4):763-75. PubMed ID: 16968658
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity comparision of Listeria monocytogenes inactivated by gamma-irradiation or traditional treatments].
Dong H; Jiao X; Pan Z; Yin Y; Sun L; Liu S
Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):269-73. PubMed ID: 19445186
[TBL] [Abstract][Full Text] [Related]
12. Killed but metabolically active vaccines.
Dubensky TW; Skoble J; Lauer P; Brockstedt DG
Curr Opin Biotechnol; 2012 Dec; 23(6):917-23. PubMed ID: 22608846
[TBL] [Abstract][Full Text] [Related]
13. Killed but metabolically active Salmonella typhimurium: application of a new technology to an old vector.
Lankowski AJ; Hohmann EL
J Infect Dis; 2007 Apr; 195(8):1203-11. PubMed ID: 17357059
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
Husseiny MI; Hensel M
Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
[TBL] [Abstract][Full Text] [Related]
15. IL-12-assisted immunization against Listeria monocytogenes using replication-restricted VSV-based vectors.
Klas SD; Lavine CL; Whitt MA; Miller MA
Vaccine; 2006 Feb; 24(9):1451-61. PubMed ID: 16310294
[TBL] [Abstract][Full Text] [Related]
16. Variable epitope library-based vaccines: shooting moving targets.
Pedroza-Roldan C; Charles-Niño C; Saavedra R; Govezensky T; Vaca L; Avaniss-Aghajani E; Gevorkian G; Manoutcharian K
Mol Immunol; 2009 Dec; 47(2-3):270-82. PubMed ID: 19853920
[TBL] [Abstract][Full Text] [Related]
17. Listeria-based vaccines for cancer treatment.
Paterson Y; Maciag PC
Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
19. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
20. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Singh R; Paterson Y
Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
